Prof. Dr. Volker Thiel

Torqur AG to Present Clinical Progress in Actinic Keratosis Program at the 7th Dermatology Drug Development Summit Europe 2026

Swiss Rockets Appoints Dana Novac, MD, MA, as Chief Medical Officer

Swiss Rockets Collaborates with Lonza to Advance Torqur’s Oncology Drug Candidate Bimiralisib into Late-Stage Clinical Development